We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Memantine Therapy for Multiple Sclerosis (Memantine-MS)

This study has been terminated.
(Unexpected side-effects: reversible and mild to moderate neurological impairment)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00638833
First Posted: March 19, 2008
Last Update Posted: June 8, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
H. Lundbeck A/S
Information provided by (Responsible Party):
Clinica Universidad de Navarra, Universidad de Navarra
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

To Top